Yatharth Hospitals Profit Rises To 57%, Revenue Up 31% YoY In 9M FY24

Yatharth Hospitals has reported operating revenue of Rs. 492.6 crores, up 31 per cent year on year (YoY) in the nine months ending December (9M FY24) and is Rs 166.8 crores, up 21 per cent YoY in the quarter ending December (Q3 FY24).

Profit after tax (PAT) is Rs 76.1 crore, up 57 per cent YoY whereas PAT margin expanded by 259 bps YoY to 15.5 per cent in 9M FY24. PAT is Rs 29.5 crore, up 39 per cent YoY; PAT margin expanded by 223 bps YoY to 17.7 per cent in Q3 FY24.

Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) is Rs 133.4 crore, up 40 per cent YoY where EBITDA margin expanded by 177 basis points (bps) YoY to 27.1 per cent in 9M FY24. EBITDA is Rs 46.4 crore, up 29 per cent YoY in Q3 FY24 where EBITDA margins expanded by 160 bps YoY to 27.8 per cent.

Bed occupancy is 53 per cent, compared to 44 per cent in 9M FY23. Bed occupancy is 52 per cent, compared to 49 per cent in Q3 FY23. Average Revenue Per Occupied Bed (ARPOB) is Rs 28,316, up 8 per cent YoY in 9M FY24 whereas ARPOB is Rs 29,309, up 14 per cent YoY and 6 per cent QoQ.

Commenting on the performance, Mr. Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said, “We are thrilled to announce another quarter of outstanding performance, with growth evident across our revenues and profitability. This quarter marked the introduction of robotic surgeries at our Noida Extension hospital and the expansion of our organ transplant program to include liver transplants. These endeavours underscore our commitment to advancing healthcare technologies and offering comprehensive, state-of-the-art solutions. These initiatives have not only improved our case mix but also boosted our Average Revenue Per Occupied Bed (ARPOB) and overall profitability. Achieving a debt-free status further enhances our financial flexibility, enabling us to allocate resources more efficiently and strategically pursue growth opportunities. Additionally, we are pleased to announce the acquisition of Asian Fidelis Hospital in Faridabad, which will further bolster our presence in the Delhi NCR market. This acquisition aligns with our company's strategy of expanding its footprint in the North India region.”